Medical-device company ZimVie lowers sales guidance as losses grow

WESTMINSTER — ZimVie Inc. (Nasdaq: ZIMV), a Westminster-based dental and spine-centric medical-device company spun off this year from Zimmer Biomet Holdings Inc. (NYSE and SIX: ZBH), is projecting a lower sales total for 2022 as it posted a growing net loss in the second quarter. 

The company posted $233.4 million in revenue for the period, a decrease of 11.5% from the $263.6 million sales total in the second quarter of 2021.

ZimVie’s net loss for the quarter was $8.7 million, compared with a loss of $4.7 million in the same period last year. 

Sales guidance for full-year 2022 has been revised down…